Current Opinion in Allergy and Clinical Immunology

Article	Citations
Primary immune regulatory disorders: a growing universe of immune dysregulation	52
Global immunoglobulin supply: steaming towards the iceberg?	44
Hymenoptera venom-induced anaphylaxis and hereditary alpha-tryptasemia	30
Clinical phenotypes of adult atopic dermatitis and related therapies	30
Tolerance mechanisms in allergen immunotherapy	29
Vaccine allergy: evidence to consider for COVID-19 vaccines	28
Rubella virus-associated chronic inflammation in primary immunodeficiency diseases	24
The role of atopy in asthma development and persistence	23
Can patients with oral allergy syndrome be at risk of anaphylaxis?	23
Omalizumab as monotherapy for food allergy	22
Artificial stone silicosis	22
Vernal keratoconjunctivitis and keratoconus	22
COVID-19 and X-linked agammaglobulinemia (XLA) – insights from a monogenic antibody deficiency	22
Atopic dermatitis and its relation to food allergy	22
Small-airway dysfunction in paediatric asthma	21
Omalizumab as an adjuvant in food allergen immunotherapy	21
Childhood asthma in the new omics era: challenges and perspectives	20
Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host–environmental interactions	20
Mechanism and diagnosis of protein contact dermatitis	20
Mechanisms underlying host defense and disease pathology in response to severe acute respiratory syndrome (SARS)-CoV2 infection: insights from inborn errors of immunity	19
The role of IL-17, IL-23 and IL-31, IL-33 in allergic skin diseases	18
Update on omalizumab in allergen immunotherapy	18
Antibody therapy for COVID-19	17
Microbiota in non-IgE-mediated food allergy	16
Current state of occupational latex allergy	16

COVID-19 in complex common variable immunodeficiency patients affected by lung diseases	16
Epithelial-to-mesenchymal transition in neutrophilic chronic rhinosinusitis	15
Cleaners and airway diseases	14
Biological agents for severe asthma: the evolution of the at-home self-injection approach	14
Vitamin D: can the sun stop the atopic epidemic?	14
Choice of biologics in asthma endotypes	14
Cow's milk allergy	14
Omalizumab and other biologics in drug desensitization	14
Allergic conjunctivitis in children: current understanding and future perspectives	14
Adverse reactions to vancomycin and cross-reactivity with other antibiotics	14
Application of exhaled nitric oxide (FeNO) in pediatric asthma	14
Inflammatory endotypes of CRSwNP and responses to COVID-19	13
Role of clinical history in beta-lactam hypersensitivity	13
Autologous serum eye drops for ocular surface disorders	13
Gastroesophageal reflux and asthma: when, how, and why	12
Artificial intelligence and the hunt for immunological disorders	12
Eosinophilic esophagitis as a complication of food oral immunotherapy	12
Asthma, severe acute respiratory syndrome coronavirus-2 and coronavirus disease 2019	11
Eosinophilic gastroenteritis: epidemiology, diagnosis, and treatment	11
Novel vaccines for allergen-specific immunotherapy	11
Epidemiology of anaphylaxis	11
New guidance on the regulation of allergen products: key aspects and outcomes	11
The impact of obesity on immune function in pediatric asthma	11
Food allergy: how expensive are they?	11
Fractional exhaled nitric oxide and asthma treatment adherence	11
Adult vernal keratoconjunctivitis	11
Probiotics in food allergy	10
Occupational exposures and idiopathic pulmonary fibrosis	10
The show must go on: an update on clinical experiences and clinical studies on novel pharmaceutical developments for the treatment of atopic dermatitis	10
Host–microbiome intestinal interactions during early life: considerations for atopy and asthma development	10
Precision medicine in cow's milk allergy	10
Predicting the course of asthma from childhood until early adulthood	9
Unique features of non-IgE-mediated gastrointestinal food allergy during infancy in Japan	9
Allergen immunotherapy and biologics in respiratory allergy: friends or foes?	9
Alpha1-antitrypsin deficiency and asthma	9
Urticaria and the gut	9
COVID-19 and autoimmune diseases: is there a connection?	9
Genetics and epigenetics of allergy	9
Angioedema without urticaria: novel findings which must be measured in clinical setting	8
Clinical and biological markers in disease and biologics to treat chronic rhinosinusitis	8
Grading the severity of anaphylaxis	8
Chronic rhinosinusitis: phenotypes and endotypes	8
Occupational aspects of irritable larynx syndrome	8
Food protein-induced enterocolitis syndrome: epidemiology and comorbidities	8
Biologics for eosinophilic granulomatosis with polyangiitis	8
The allergic eye: recommendations about pharmacotherapy and recent therapeutic agents	8
Prevention of baker's asthma	8
Air pollution and childhood asthma	8
Basophil activation test in food allergy: is it ready for real-time?	8
Nucleic acid vaccines and CpG oligodeoxynucleotides for allergen immunotherapy	8

Exploring the origin and regulatory role of mast cells in asthma	8
An update on the epigenetics of asthma	8
Immediate hypersensitivity reactions to steroids and steroid containing medications	8
Severe asthma: what is new in the new millennium	8
Oral mite anaphylaxis: who, when, and how?	8
Pediatric asthma in developing countries: challenges and future directions	7
Replacing defective thymus function	7
Allergen immunotherapy for pediatric asthma: current evidence and knowledge gaps	7
Anaphylactic reactions to biological drugs	7
Non-IgE-mediated food allergy during infancy	7
Is asthma a risk factor for coronavirus disease-2019 worse outcomes? The answer is no, but …	7
Exhaled nitric oxide in asthma: from diagnosis to management	7
Epinephrine in anaphylaxis: too little, too late	7
Biologicals for the prevention of anaphylaxis	7
Classifying cephalosporins: from generation to cross-reactivity	7
Neutrophilic inflammation in chronic rhinosinusitis	7
Emerging approaches in the diagnosis and therapy in shellfish allergy	7
Addressing the impact of ethnicity on asthma care	7
Molecular diagnosis usefulness for idiopathic anaphylaxis	7
Biologics and severe asthma in children	6
Biologics as treatment options for anaphylaxis	6
Cellular interactions in aspirin-exacerbated respiratory disease	6
Resolving the genetics of human tryptases: implications for health, disease, and clinical use as a biomarker	6
Anaphylaxis and digital medicine	6
Real-life studies in allergen immunotherapy	6
Drug allergy management in the elderly	6
Paediatric allergy practice in the era of coronavirus disease 2019	6
Flavonoid and cannabinoid impact on the ocular surface	6
Mast cell activation syndrome: is anaphylaxis part of the phenotype? A systematic review	6
Strengthening the case for intralymphatic immunotherapy	6
Clinically significant differences in patient-reported outcomes evaluations in chronic spontaneous urticaria	6
Atopic dermatitis endotypes: knowledge for personalized medicine	5
Updates in diagnosis and management of paediatric mastocytosis	5
Occupational respiratory and skin diseases among workers exposed to metalworking fluids	5
Food allergy in adults in Europe: what can we learn from geographical differences?	5
Anaphylaxis across Europe: are pollen food syndrome and lipid transfer protein allergy so far apart?	5
Neurostimulation for dry eye disease	5
How E-cigarettes and vaping can affect asthma in children and adolescents	5
Role of tissue-resident memory T cells in the pathophysiology of allergic contact dermatitis	5
Nanoparticles in allergen immunotherapy	5
Wheat oral immunotherapy	5
Allergy prevention through breastfeeding	5
Pulmonary function testing for the diagnosis of asthma in preschool children	5
Safety of anti-inflammatory drugs in children with asthma	5
Anaphylaxis in elderly people	5
Investigation of perioperative hypersensitivity reactions: an update	5
Management of adverse reactions induced by chemotherapy drugs	5
Impact of the exposome on food allergy development	5
Food protein-induced enterocolitis syndrome epidemiology, diagnosis, and treatment	5
Diagnostic approach to occupational rhinitis: the role of nasal provocation tests	4
Thymic stromal lymphopoietin and alarmins as possible therapeutical targets for asthma	4
Natural history and long-term follow-up of Hymenoptera allergy	4
Personalized management for unmet needs with food allergy	4
Evaluating the glucagon-like peptide-1 receptor in managing asthma	4
Epidemiology of non-IgE-mediated food allergies: what can we learn from that?	4
Update on irritant-induced occupational asthma	4
Recent advances in the diagnosis and management of tree nut and seed allergy	4
How molecular allergology can shape the management of allergic airways diseases	4
Hymenoptera allergy and anaphylaxis: are warmer temperatures changing the impact?	4
Role of type-2 innate lymphoid cells (ILC2s) in type-2 asthma	4
Occupational causes of chronic obstructive pulmonary disease: an update	4
An immunologist's perspective on anti-COVID-19 vaccines	4
New concepts for the pathogenesis and management of aspirin-exacerbated respiratory disease	4
Anaphylaxis and Coronavirus Disease 2019 vaccine: a danger relationship?	4
Chemokines in allergic conjunctivitis	4
Occupational inhalant allergy in food handling occupations	4
Food-labeling issues for severe food-allergic consumers	4
Prevention of food allergy: can we stop the rise of IgE mediated food allergies?	4
Immunodeficient patient experience of emergency switch from intravenous to rapid push subcutaneous immunoglobulin replacement therapy during coronavirus disease 2019 shielding	4
Applying the new guidelines to asthma management in children	4
Characteristics of allergen profile, sensitization patterns and Allergic Rhinitis in SouthEast Asia	3
Olfactory and taste dysfunctions in COVID-19	3
Pathology of T-cell-mediated drug hypersensitivity reactions and impact of tolerance mechanisms on patient susceptibility	3
New approaches in childhood asthma treatment	3
Role of pharmacogenomics in T-cell hypersensitivity drug reactions	3
The challenges and facilitators of self-management in pediatric asthma	3
Dietary strategies for the prevention of asthma in children	3
Updates on treatment options in aspirin exacerbated respiratory disease	3
Optimal use of intranasal corticosteroids and intranasal saline, is there a clear answer?	3
Emerging developments in the forefront of peanut oral immunotherapy	3

New causes of immunologic occupational asthma 2014–2020	3
Biologics in eosinophilic esophagitis	3
Ocular mucous membrane pemphigoid: novel treatment strategies	3
Severe asthma and personalized approach in the choice of biologic	3
Systemic hypereosinophilic syndromes: when autoimmunity is Th2 mediated	3
The role of eosinophils in immunotherapy	3
Evidence-based management of eczema: five things that should be done more and five things that should be dropped	3
Update on the use of allergen challenge chambers in immunotherapy: clinical implications	3
Social determinants of health and asthma	3
The clinical impact of cross-reactions between allergens on allergic skin diseases	3
Gene therapy for inborn error of immunity – current status and future perspectives	3
Comparison of structural components and functional mechanisms within the skin vs. the conjunctival surface	3
Drug allergy desensitization is not a unique recipe	3
Corneal complications of rheumatoid arthritis	3
Recent advances in the treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome	3
Current strategies for phenotyping and managing asthma in preschool children	3
Atopic endotypes as a modulating factor for SARS-CoV-2 infection: mechanisms and implications	3
Consequences of severe asthma exacerbations	3
Economic burden of drug-induced anaphylaxis: what can we do better?	3
β-Blockers and angiotensin-converting enzyme inhibitors with sublingual immunotherapy: are risks related to individual product safety profile?	3
Psychosocial impact of ocular surface allergic inflammatory disorders	3
Global patterns of drug allergy-induced fatalities: a wake-up call to prevent avoidable deaths	3